APA (7th ed.) Citation

X, Z., J, W., Q, C., X, W., W, M., J, M., . . . C, W. (2024). Systemic bevacizumab for treatment of recurrent respiratory papillomatosis. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 281(4), 1865. https://doi.org/10.1007/s00405-023-08430-x

Chicago Style (17th ed.) Citation

X, Zhao, Wang J, Chen Q, Wu X, Mao W, Ma J, Fang R, He P, and Wei C. "Systemic Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis." European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 281, no. 4 (2024): 1865. https://doi.org/10.1007/s00405-023-08430-x.

MLA (9th ed.) Citation

X, Zhao, et al. "Systemic Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis." European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, vol. 281, no. 4, 2024, p. 1865, https://doi.org/10.1007/s00405-023-08430-x.